Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Bioprospecting
‘‘Adding value to Indigenous Knowledge through Scientific Innovation’
INTERNATIONAL WORKSHOP ON INDIGENOUS KNOWLEDGE
Benoni, South Africa
9-11 February 2005
Marthinus HorakMarthinus HorakBioprospecting ProgrammeBioprospecting Programme
CSIR Bio/CSIR Bio/ChemtekChemtekPretoriaPretoria
THE WORLD BANK
Bioprospecting
• Local knowledge• Unique to every culture or society• Basis for local-level decision making in :
– Agriculture, health care, food preparation, education, natural resource management, etc.
• Provides problem solving strategies for communities
• Community rather than individual knowledge• Tacit knowledge, difficult to codify,
embedded in community practices, etc.
IKS definition (World Bank)
Bioprospecting
• IKS is different, but equal, to ‘Western’ knowledge systems
• IKS may have ancient origins, but is relevant in day-to-day lives of people
• Continues to evolve• Is highly validated in context of
community/local use
IKS – some thoughts
Bioprospecting
• Millenium Development Goals:– Eradicate poverty and hunger, improve
education, gender equality, health issues, environmental sustainability and partnerships for development
• IKS can contribute significantly to development– Must be leveraged with other knowledge
resources– Value addition to IKS through scientific
innovation can create new benefits for society– Requires partnerships
IKS in context of Global Development
Bioprospecting
The search for valuable chemical and genetic constituents of
biodiversity
What is Bioprospecting?
Bioprospecting
Add maximum value to bio-resources and indigenous knowledge through
consortium-based research, thereby creating economic and social benefit
for all stakeholders
Vision for Bioprospecting
Bioprospecting
Bioprospecting strategy
Scientific Innovation
Biodiversity
Indigenous Knowledge
Bioprospecting
• 19 500 indigenous plant species• 8% of all plant species on earth• 60% endemicity• Mainly unexplored as source of natural
medicines– 25% of world’s pharmaceuticals are
derived from plants
S A’s plant biodiversity
Bioprospecting
• 200 000 Traditional Healers in SA• >70% of population regularly consult a
Healer• Possibly 3 000 - 5 000 plants may have
biological activity
Indigenous Knowledge …
Bioprospecting
CSIR signs agreement with Traditional Healers (1999)
Bioprospecting
Bioprospecting
Drug Development Cycle
DiscoveryDevelopment: Phase I, II, III
and regulatory approval
Commercial Sales
Time
Multinational companies
Cum
ulat
ive
Inve
stm
ent
CSIR Bioprospecting
Lead Discovery
Early ProofOf Concept
Bioprospecting
Classic, rational approach to drug discovery
Therapeuticconcept
EfficacyAssay (HTS)
Screencompounds
In vitro models
In vivo Pharmaco-dynamics
Toxicology
NDAsubmission
New druglaunch
PreclinicalDevelopment
compound
patent
analytical
production
Pharmacokinetics
Phase 1Clinical study
Phase 2Clinical study
Phase 3Clinical study
n-th NCE First NCE,iterate
Evolve SARand MC concepts
INDClinical
Developmentcompound
Bioprospecting
Bioprospecting in partnership with Traditional Healers
Therapeuticconcept
EfficacyAssay (HTS)
Screencompounds
In vitro models
In vivo Pharmaco-dynamics
Toxicology
NDAsubmission
New druglaunch
PreclinicalDevelopment
compound
patent
analytical
production
Pharmacokinetics
Phase 1Clinical study
Phase 2Clinical study
Phase 3Clinical study
n-th NCE First NCE,iterate
Evolve SARand MC concepts
INDClinical
Developmentcompound
Bioprospecting
• High-throughput plant collection and extraction
• Data and information management• Nuclear magnetic resonance, mass
spectrometry, high-pressure liquid chromatography, gas chromatography
• Plant biotechnology including tissue culture laboratories
• Clinical Supplies Unit, Botanical Supplies unit
• Good Farming Practice, Good Manufacturing Practice, Good Laboratory Practice
CSIR Bioprospecting facilities
Bioprospecting
• No research group, company, country or region can control full value chain inBioprospecting
• CSIR Consortium consists of:– Traditional Healers– Universities– Research institutes– Communities– Micro-enterprises
Consortium-based research: key component of Bioprospecting
Bioprospecting
CSIR Bioprospecting partners
Bioprospecting
• The needle is hidden in a very big haystack– Nearly 250 000 plant species– 50 years of ‘modern’ research data – Centuries of experiential learning of Traditional
Healers • Data and information security• Communication between representatives of
different knowledge systems• Stimulate scientific innovation• Support quality assurance procedures e.g.
Good Laboratory Practice
Knowledge management challenges in Bioprospecting
Bioprospecting
• Artificial neural networks may be constructed to assist recognition of patterns such as ecosystem-species-biological activity relationships
• Aimed at implementation in southern African region, based on experimental data from South African species
Artificial Intelligence
Bioprospecting
Intellectual Capital
Protection of intellectual assets:what are intellectual assets?
•intangible: learning, experience, capability to innovate•People based
Intellectual Assets
Intellectual Property
•information, technology, Indigenous Knowledge •Product/technologybased
•Unique and highlyvaluable productor technology
Bioprospecting
Intellectual Capital
Creation and protection of intellectual assets
•Involve owners of knowledge as partners in Bioprospecting
Intellectual Assets
Intellectual Property (IP)
•Keep secret•Trademark/brand•Develop into IP
•Patent
Search, record and add value
Innovate
Bioprospecting
• Creation and licensing of patented Intellectual property– Very long development periods– Difficulty typically underestimated– Rewards can be very high
• Production and sale of biodiversity products e.g. self-medication products (not patented)– Regulatory environment is complex– Requires strong brand identity
Commercialization of Bioprospecting products
Bioprospecting
Risk vs. Return in Bioprospecting
Degree of value added
Profitpotential
Low
Low
High
High
Patenteddrug leads
Herbalproducts
Bioprospecting
Anti-obesity agent from Hoodia
Bioprospecting
Hoodia in its natural habitat
Bioprospecting
Hoodia: cultivation site
Bioprospecting
Anti-obesity agent (P57): structure elucidation
Bioprospecting
• Establishment of community-owned businesses, based on agro-processing
• Focus on alternative crops e.g. aromatic and medicinal plants
• Technology transfer and skills development allow value-adding processing
• Communities become partners in commercialization of bioprospecting successes
Community involvement
Bioprospecting
Bioprospecting
Current activities• Signed benefit-sharing agreements with
owners of Indigenous Knowledge (San Council and Traditional Healer Trust)
• Signed bioprospecting agreement with Namibia (2005)
• Collected one-third of SA’ plant biodiversity (>8 000 plant species)
• Investigating more than 400 ethnobotanical leads provided by Traditional Healers
Bioprospecting
IKS-led drug leads under development
• Asthma and allergies• Inflammation• Arthritis• Benign prostatic hyperplasia• HIV• Wound healing• Malaria
Bioprospecting
THE WORLD BANK
Challenges for this IKS Workshop• Establish framework for collaboration:
World Bank, GRA and Traditional Healers• Identify pilot projects aimed at validation
of IK• Develop roadmap for the partnership, aimed
at implementation of IK in support of sustainable development
• Present outcomes at 4th Annual Meeting of GRA Principals and future World Bank Conference
Bioprospecting
THE WORLD BANK
Thank you for your attention